Work

PA-299 Matching-Adjusted Indirect Comparisons (MAICs) of Iberdomide, Daratumumab (DARA), and Dexamethasone (IberDd) Versus Regimens Containing DARA and IMiDs in Relapsed/Refractory Multiple Myeloma (RRMM)

Year: 2026

Type: conference-abstract

Source: Clinical Lymphoma Myeloma & Leukemia

DOI: 10.1016/s2152-2650(26)03662-1

Authors: Ola Landgren, Maria Gavriatopoulou, Hang Quach, Fredrik Schjesvold, Vania Hungria, María-Victoria Mateos, Nisha S. Joseph, Chengcheng Fu, Saulius Girnius, Kevin Towle, Jenny Chen, Sichen Liu, Elissa Min, Ying Qiu, Paulo Maciag, Gabriela Hernandez Rivera, Yu-Hsuan Shih, Sagar Lonial

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7213914334

Cites:

Cited by:

Related to: 10